Healius
Healius is a leading Australian diagnostics company providing essential healthcare services through a vast network of labs and diagnostic centers. With a focus on accessible and affordable healthcare, Healius leverages digital technologies to enhance service delivery and patient care.
Short position
Healius (ASX:HLS) has 2.54% of its shares on issue reported as short positions as of 5 Oct 2026, or about 18,426,064 shares. Over the past 30 days that figure has fallen 5.72 percentage points, and over 90 days it has fallen 7.48 percentage points. Its highest recorded short interest was 10.81% in June 2026. HLS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Healius (HLS) company profile
Profile, insiders and operations
Company
AI-generated research profile of Healius
HLS intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links